Get the Stockscreener App
55.60
0.50%
-0.28
After Hours:
55.60
Disc Medicine Inc Stock (IRON) Latest News
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
WilmerHale Advises Underwriters in Upsized $259.3 Million Follow-on Public Offering of Disc Medicine - WilmerHale
JPMorgan Chase & Co. Purchases 2,257 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
How To Trade (IRON) - Stock Traders Daily
Stifel Nicolaus Increases Disc Medicine (NASDAQ:IRON) Price Target to $94.00 - MarketBeat
Stifel raises Disc Medicine stock target to $94, maintains Buy By Investing.com - Investing.com Canada
Stifel raises Disc Medicine stock target to $94, maintains Buy - Investing.com India
Disc Medicine (NASDAQ:IRON) Sees Large Volume Increase After Analyst Upgrade - MarketBeat
Disc Medicine’s (IRON) Outperform Rating Reiterated at Wedbush - Defense World
Disc Medicine (NASDAQ:IRON) Sees Unusually-High Trading Volume on Analyst Upgrade - Defense World
FY2026 Earnings Estimate for Disc Medicine Issued By Wedbush - MarketBeat
Disc raises $225.5m as it eyes approval of rare skin disorder drug - Yahoo Finance
Disc Medicine announces pricing of $225.5M upsized public offering - MSN
Cantor Fitzgerald Comments on Disc Medicine FY2025 Earnings - Defense World
Disc Medicine Raises $225.5M in Upsized Public Offering to Advance Bitopertin Development - StockTitan
Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire
Disc Medicine (NASDAQ:IRON) Shares Gap DownHere's Why - MarketBeat
Scotiabank Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
FY2028 Earnings Estimate for Disc Medicine Issued By Wedbush - MarketBeat
Cantor Fitzgerald Estimates Disc Medicine FY2025 Earnings - MarketBeat
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire
Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria and Shares Plans for NDA Submission - Marketscreener.com
Disc Medicine: Potential Promise Amid Uncertainty (NASDAQ:IRON) - Seeking Alpha
Disc Medicine Announces $200M Public Offering to Advance EPP Treatment Pipeline - StockTitan
Disc Medicine (NASDAQ:IRON) Receives Buy Rating from HC Wainwright - MarketBeat
Wedbush Reaffirms "Outperform" Rating for Disc Medicine (NASDAQ:IRON) - MarketBeat
Disc Medicine Announces Successful Type C Meeting with FDA - GlobeNewswire
Disc Medicine Secures FDA Fast-Track Path for Groundbreaking EPP Treatment Bitopertin - StockTitan
Disc Medicine to Host FDA Meeting Update Call on Bitopertin EPP Treatment Progress - StockTitan
Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP) - GlobeNewswire
Disc Medicine, Inc. (NASDAQ:IRON) Short Interest Up 6.6% in December - MarketBeat
Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Exciting News From a Fast-Growing Biopharma! New Employee Benefits Unveiled! - Zaman
Disc Medicine's SWOT analysis: rare blood disorder stock shows promise By Investing.com - Investing.com Australia
Disc Medicine's SWOT analysis: rare blood disorder stock shows promise - Investing.com India
How the (IRON) price action is used to our Advantage - Stock Traders Daily
Wedbush Reiterates Outperform Rating for Disc Medicine (NASDAQ:IRON) - Defense World
Disc Medicine (NASDAQ:IRON) Earns "Outperform" Rating from Wedbush - MarketBeat
Disc Medicine Highlights 2025 Strategy and Financial Updates - TipRanks
Disc Medicine Highlights Recent Achievements Across Hematology Portfolio and Key Business Objectives and Milestones for 2025 - The Manila Times
Disc Medicine Highlights Recent Achievements Across - GlobeNewswire
Disc Medicine Advances EPP Treatment: FDA Fast-Track Talks & $178M Funding Boost Clinical Pipeline - StockTitan
Disc medicine chief legal officer sells $470,657 in stock By Investing.com - Investing.com Australia
Disc Medicine, Inc. (NASDAQ:IRON) Insider Sells $470,625.00 in Stock - MarketBeat
Disc medicine chief legal officer sells $470,657 in stock - Investing.com India
When (IRON) Moves Investors should Listen - Stock Traders Daily
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
John D. Quisel Sells 13,012 Shares of Disc Medicine, Inc. (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine CEO sells over $806,000 in stock By Investing.com - Investing.com Nigeria
Disc Medicine CEO sells over $806,000 in stock - Investing.com
Disc Medicine, Inc. (NASDAQ:IRON) Shares Could Be 29% Below Their Intrinsic Value Estimate - Simply Wall St
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):